Abstract
A study on chromosomal abnormalities has raised concerns that medication with methylphenidate (MPH) for attention-deficit/hyperactivity disorders (ADHD) might increase the risk of cancer. We performed a rigorous test of the association between cancer and MPH and other drugs used for ADHD, based on data from nationwide Danish registers.
| Original language | English |
|---|---|
| Journal | Journal of Child and Adolescent Psychopharmacology |
| Volume | 23 |
| Issue number | 3 |
| Pages (from-to) | 208-13 |
| Number of pages | 6 |
| ISSN | 1044-5463 |
| DOIs | |
| Publication status | Published - 2013 |